<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01986374</url>
  </required_header>
  <id_info>
    <org_study_id>HCG 2013</org_study_id>
    <nct_id>NCT01986374</nct_id>
  </id_info>
  <brief_title>Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF</brief_title>
  <official_title>Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servy Massey Fertility Insititute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servy Massey Fertility Insititute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest
      that placing HCG into the uterus prior to embryo transfer can enhance implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is in pilot phase, uncontrolled. The risks appear to be minimal and there are
      conflicting new reports being announced.

      A small amount of fluid with HCG is injected into the uterus. HCG is a potent signal to the
      uterus for preparation for implantation.

      This is not a funded study. Three published studies suggest the approach is valid; one
      refutes the concept.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HCG enhances pregnancy rate</measure>
    <time_frame>9 months.</time_frame>
    <description>compare pregnancy rates to established clinical norms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
    <time_frame>18 months</time_frame>
    <description>compare implantation rate per embryo to clinical norms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ongoing pregnancy rate</measure>
    <time_frame>22 months</time_frame>
    <description>compare success to clinical norms</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>HCG is introduced with small catheter.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>phase 1 non randomized pilot</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HCG is introduced</intervention_name>
    <description>must have good blastocysts</description>
    <arm_group_label>HCG is introduced with small catheter.</arm_group_label>
    <other_name>Improve results of IVF and embryo transfer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - infertility patients undergoing IVF with good expectation of two embryos day 3 or day 5.
        must speak and read English. Includes donor eggs.

        Exclusion Criteria:abnormal uterus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>47 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joe B Massey, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Servy Massey Fertilty Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joe B Massey, MD</last_name>
    <phone>4042287199</phone>
    <email>drmassey@ivfga.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dawn Cooke, MA</last_name>
    <phone>4042287199</phone>
    <email>dawnc@ivfga.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Servy Massey Fertility Insititute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30327</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Cook, MA</last_name>
      <phone>404-228-7199</phone>
      <email>dawnc@ivfga.com</email>
    </contact>
    <investigator>
      <last_name>Joe B Massey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mansour R, Tawab N, Kamal O, El-Faissal Y, Serour A, Aboulghar M, Serour G. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril. 2011 Dec;96(6):1370-1374.e1. doi: 10.1016/j.fertnstert.2011.09.044. Epub 2011 Nov 1.</citation>
    <PMID>22047664</PMID>
  </reference>
  <reference>
    <citation>Zarei A, Parsanezhad ME, Younesi M, Alborzi S, Zolghadri J, Samsami A, Amooee S, Aramesh S. Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial. Iran J Reprod Med. 2014 Jan;12(1):1-6.</citation>
    <PMID>24799855</PMID>
  </reference>
  <reference>
    <citation>Santibañez A, García J, Pashkova O, Colín O, Castellanos G, Sánchez AP, De la Jara JF. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study. Reprod Biol Endocrinol. 2014 Jan 29;12:9. doi: 10.1186/1477-7827-12-9.</citation>
    <PMID>24476536</PMID>
  </reference>
  <reference>
    <citation>Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD, Kim TJ, Scott RT Jr. Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2014 Dec;102(6):1591-5.e2. doi: 10.1016/j.fertnstert.2014.08.006. Epub 2014 Sep 16.</citation>
    <PMID>25234040</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2013</study_first_submitted>
  <study_first_submitted_qc>November 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2013</study_first_posted>
  <last_update_submitted>November 25, 2014</last_update_submitted>
  <last_update_submitted_qc>November 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IVF , embryo implantation, HCG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

